Sanjay Mishra Source Confirmed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Research Program Manager
John Brown University
staff
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Sanjay Mishra is a Research Program Manager at John Brown University whose work addresses pressing issues in healthcare and cellular biology. His research portfolio includes significant contributions to understanding the multifaceted impacts of COVID-19, particularly among vulnerable populations. Mishra's work has investigated the association of anticancer therapies with COVID-19 severity, the efficacy of convalescent plasma therapy in patients with hematologic cancers, and the rates of breakthrough infections after COVID-19 vaccination in cancer patients. Additionally, he has explored racial disparities in COVID-19 outcomes within cancer patient populations and the interplay between immunosuppression and immunotherapy in the context of COVID-19. Beyond COVID-19, Mishra's interests extend to cellular transport and secretion mechanisms, the role of connexins in lens biology, and heat shock protein research.
Metrics
- h-index: 29
- Publications: 127
- Citations: 4,793
Selected Publications
- Summarizing clinical evidence utilizing large language models for cancer treatments: a blinded comparative analysis (2025) DOI
- Building an Inclusive Data Literacy Community (2025) DOI
- Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema (2025) DOI
- Inferring gender from first names: Comparing the accuracy of Genderize, Gender API, and the gender R package on authors of diverse nationality (2024) DOI
- Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment (2024) DOI
- Could This Be Coccidioidomycosis? A Complex Empyema (2024) DOI
- Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis (2024) DOI
- The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study (2024) DOI
- Inferring Gender from First Names: Comparing the Accuracy of Genderize, Gender API, and the gender R Package on Authors of Diverse Nationality (2024) DOI
- Data from Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study (2023) DOI
- ROUGH IDEAL CONVERGENT SEQUENCE SPACES OF BOUNDED LINEAR OPERATORS (2023) DOI
- Author response: Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study (2023) DOI
- Who goes first? Patterns of cancer drug approvals across four major regulatory authorities: EMA, FDA, Health Canada, and PMDA. (2023) DOI
- Patterns of co-first and co-last authorship in cancer phase 3 trials. (2023) DOI
- Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study (2023) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics